Finance Pfizer’s Latest Ozempic Competitor Just Flopped (Again). Is the Stock Still a Buy? by CoinNews December 8, 2023 by CoinNews December 8, 2023 On Dec. 1, Pfizer (PFE 0.52%) reported some less-than-great news to investors. In short, its… Read more 0 FacebookTwitterPinterestEmail
Finance AstraZeneca Is Trying to Make an Ozempic Competitor (Again), but Don’t Rush to Buy the Stock by CoinNews November 17, 2023 by CoinNews November 17, 2023 U.K.-based AstraZeneca (AZN 0.52%) is now gearing up for the second time to develop a… Read more 0 FacebookTwitterPinterestEmail